DMAC
DiaMedica Therapeutics Inc
8.40$
+1.0%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -99.8% | +0.0% | +25.0% | +68,730.0% | -99.8% | +0.0% | -72.7% | +500.0% | -22.2% | -21.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +12.4% | 0.0% | +6.9% | +26.9% | +29.8% | -12.6% | +2.9% | +10.6% | +4.1% | +19.2% | +2.1% | – | |
| – | +15.2% | -4.9% | -17.2% | +11.1% | +2.6% | +27.7% | -12.2% | +18.8% | -3.2% | -0.8% | -6.0% | – | |
| – | +13.4% | -1.8% | -1.8% | +22.1% | +22.3% | -3.3% | -1.7% | +12.8% | +2.0% | +13.8% | -3.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +214.3% | -68.2% | +0.0% | +0.0% | +28.6% | -33.3% | +0.0% | +0.0% | +66.7% | -170.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.